Merck to Return to Growth during Fiscal 2024
Thanks to its set-up with three business sectors, Merck expects to see on average stable sales in fiscal 2023, despite a difficult market environment in Life Science and Electronics. The company still assumes an organic sales development of 2% to +2%, leading to net sales of 20.5 billion to 21.9 billion in total.